Research monograph · 28-amino-acid thymic peptide
Immune Response Studies
This monograph collects what the published literature reports about Thymosin Alpha-1 — its mechanisms, the areas it is studied in, its molecular record and the sources behind them. It occurs naturally as a cleavage product of a larger precursor protein, and research examines T-cell signaling and immune-response endpoints — making it one of the more clinically characterized compounds in this catalog.
For laboratory research use only — not for human or animal use
Mechanisms
Thymic Immune Modulation
First isolated from the thymus, where T-cells mature. It occurs naturally as a cleavage product of a larger precursor, and T-cell maturation remains the endpoint it is most associated with.
Toll-Like Receptor Activation
Reported to signal through TLR2 and TLR9 on dendritic cells — the innate arm — which is how a peptide characterized in adaptive immunity came to be studied on both sides.
NK & Th1 Cytokine Modulation
Natural-killer cell activity and a Th1-weighted cytokine profile are the measured outputs, making this among the more clinically characterized compounds in the catalog.
Studied applications
T-cell maturation is the endpoint the peptide is most associated with, following from its isolation from the thymus.
Garaci et al. 2007
Antiviral endpoints are measured through immune activation rather than through any direct action on the virus.
Loggi et al. 2020
Tumour models measure immune-mediated response, an application that follows from the same T-cell mechanism.
Costantini et al. 2019
A Th1-weighted cytokine profile is the measured output, alongside natural-killer cell activity.
Romani et al. 2012
What the published work measures
The endpoints reported across the literature for this compound. The figures belong to the individual papers, not to us.
Reference values
Scroll for full molecular data →
| Molecular weight | 3,108.29 g/mol |
|---|---|
| Molecular formula | C129H215N33O55 |
| Physical form | Lyophilized Powder |
| Documented purity | Quantified by HPLC, reported per lot |
| Storage | Store at -20°C, protected from light |
| Available sizes | 10mg |
FAQ
Thymosin Alpha-1 is a 28-residue peptide first isolated from the thymus, the organ where T-cells mature. It occurs naturally as a cleavage product of a larger precursor protein, and research examines T-cell signaling and immune-response endpoints — making it one of the more clinically characterized compounds in this catalog.
Published research on Thymosin Alpha-1 concentrates on T-Cell Research, Viral-Response Models, Tumour-Immunity Models and Cytokine Regulation. Each of those areas is summarised further up this page with the citation it comes from, and the full reference list — 4 indexed publications — sits at the bottom. Study designs and concentrations vary considerably between publications, so the primary sources are worth reading directly.
The literature describes Thymosin Alpha-1 acting across Thymic Immune Modulation, Toll-Like Receptor Activation and NK & Th1 Cytokine Modulation, reported respectively as T-Cell Maturation, TLR Signaling and Cytokine / NK. Those pathways are drawn from preclinical models rather than clinical work, and they describe what has been observed rather than a settled mechanism — the individual pathway cards above cite what each one is based on.
Thymosin Alpha-1 has a molecular formula of C129H215N33O55 and an average mass of 3108.29 g/mol. It is indexed under CAS 62304-98-7. It ships as lyophilized powder. Those are nominal reference values for the parent compound. The identity of the specific material you receive is confirmed by mass spectrometry and reported on that lot's certificate.
Store the sealed vial at Store at -20°C, protected from light, protected from light and moisture, and let it reach room temperature before opening so condensation does not form on cold powder. Keep reconstituted solution refrigerated and avoid repeated freeze-thaw cycles — solutions are far less stable than lyophilized powder.
No. Thymosin Alpha-1 is supplied strictly for in-vitro laboratory research and development. It is not a drug, food, supplement or cosmetic, it has not been evaluated by the FDA, and it is not intended for human or animal consumption, ingestion, injection or any in-vivo use. Ordering confirms you are a qualified researcher or institution purchasing on that basis.
Cited sources
Independent published research indexed from PubMed — not Routine Peptides claims.
Before you order
Every production run is analyzed by an independent laboratory, and the certificate for your lot travels with the order — not a catalog-wide document, and not a summary written by us.
